Hypercell Technologies
Hypercell Technologies is dedicated to early identification and management of biological contaminants in the food chain, from production to transformation. They develop rapid, accurate, point-of-care diagnostic tools to detect biological contaminants quickly and precisely, aiming to revolutionize food safety testing and prevent contamination and disease spread.
Industries
Nr. of Employees
small (1-50)
Hypercell Technologies
Atlanta, Georgia, United States, North America
Products
Point-of-care diagnostic platform
A compact testing platform and associated assays designed to detect biological contaminants in the food chain on-site, delivering laboratory-comparable sensitivity with results in under 60 minutes and without centralized laboratory equipment.
Passive antibody biotherapeutics for production animals
Antibody-based therapeutic products intended to provide immediate, single-dose protection or treatment in production animals to reduce symptoms, virus shedding, and transmission.
Point-of-care diagnostic platform
A compact testing platform and associated assays designed to detect biological contaminants in the food chain on-site, delivering laboratory-comparable sensitivity with results in under 60 minutes and without centralized laboratory equipment.
Passive antibody biotherapeutics for production animals
Antibody-based therapeutic products intended to provide immediate, single-dose protection or treatment in production animals to reduce symptoms, virus shedding, and transmission.
Services
Cloud-based aggregation and monitoring of site-level test results to support trend analysis and proactive management across supply chains.
Collaboration with research institutions and industry partners to pilot and scale diagnostic and therapeutic solutions in production environments.
Cloud-based aggregation and monitoring of site-level test results to support trend analysis and proactive management across supply chains.
Collaboration with research institutions and industry partners to pilot and scale diagnostic and therapeutic solutions in production environments.
Expertise Areas
- Point-of-care diagnostics
- Food safety and pathogen detection
- Passive antibody therapeutics for production animals
- Diagnostic assay development and validation
Key Technologies
- Point-of-care molecular diagnostics
- Rapid pathogen detection assays (<60 minutes)
- Passive antibody therapeutics
- Cloud-based epidemiological monitoring
News & Updates
Hypercell demonstrates how in-farm rapid diagnostics and treatments can stop the spreading of infectious diseases and reduce farmers’ costs.
Hypercell has developed new tools to control infectious diseases in animals, including rapid detection and bio-therapeutics to treat diseases.
Hypercell has been featured in Forbes, won the Grow-NY business competition, and received awards at the World Agritech Innovation Summit and the French-American Entrepreneurship Award.
Hypercell Technologies, founded in 2021, is rapidly growing in the agrifoodtech sector with a focus on biological contamination detection.
Hypercell was selected for the IndieBio accelerator program, supporting biotech startups.
Hypercell was awarded the 2024 Edwin Moore Family Agriculture Innovation Prize for its innovative solutions.
Hypercell demonstrates how in-farm rapid diagnostics and treatments can stop the spreading of infectious diseases and reduce farmers’ costs.
Hypercell has developed new tools to control infectious diseases in animals, including rapid detection and bio-therapeutics to treat diseases.
Hypercell has been featured in Forbes, won the Grow-NY business competition, and received awards at the World Agritech Innovation Summit and the French-American Entrepreneurship Award.
Hypercell Technologies, founded in 2021, is rapidly growing in the agrifoodtech sector with a focus on biological contamination detection.
Hypercell was selected for the IndieBio accelerator program, supporting biotech startups.
Hypercell was awarded the 2024 Edwin Moore Family Agriculture Innovation Prize for its innovative solutions.